drugset / Trial / NCT03014843

The Effect of Naloxone and Methylnaltrexone on Esophageal Sensitivity in Health

NCT03014843

Completed 12 enrolled Universitaire Ziekenhuizen KU Leuven
RandomizedCrossoverTriple-blindBasic science

Summary

The aim of this study was to investigate the effect of naloxone (IV or IM administration) and methylnaltrexone (subcutaneous administration) on esophageal sensitivity, in a group of healthy volunteers in order to evaluate the role of endogenous opiods in symptom perception in gastro-esophageal reflux disease. Esophageal sensitivity was assessed by using a multimodal esophageal stimulation protocol where sensitivity to thermal, mechanical, electrical and chemical stimulation was tested.

Timeline

Start
2013-10
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylnaltrexone Other / unclassified 12 mg Subcutaneous
Comparator Naloxone Small molecule 20 ug/kg Intravenous

Indications

No indication recorded.